Patients with Hodgkin lymphoma who received Opdivo plus Adriamycin (doxorubicin ... 70% reported in the Adcetris group), fatigue (47% versus 51%), lower levels of neutrophils (white blood cells; 56% ...

Understand the basics of lymphoma, the differences between Hodgkin and non-Hodgkin lymphoma, and why some people may be more susceptible to this type of cancer. Your doctor can help you find the ...

It was for people with certain types of non-Hodgkin lymphoma that had come back after treatment ... a drop in the number of certain types of white blood cells, including neutrophils The most common ...

Hodgkin lymphoma is a disease where cancer cells form in the lymph system. There are two types of adult Hodgkin lymphoma: classical and nodular lymphocyte-predominant. Another type of lymphoma is ...

Patients with classic Hodgkin lymphoma (cHL) respond well to PD-1 blockade, but the underlying cellular insights are still lacking. Here, the authors use single-cell transcriptome and spatial ...

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.

Your treatment depends on several factors. These include what type of Hodgkin lymphoma you have and its stage. It also depends on your general health. The main treatments for Hodgkin lymphoma include: ...